Pro Share Advisors LLC Charles River Laboratories International, Inc. Transaction History

Pro Share Advisors LLC

  • $42.5 Billion
  • Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 13,539 shares of CRL stock, worth $2.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,539
Previous 13,563 0.18%
Holding current value
$2.26 Million
Previous $2.67 Million 6.44%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$178.58 - $220.69 $4,285 - $5,296
-24 Reduced 0.18%
13,539 $2.5 Million
Q3 2024

Nov 13, 2024
BUY
$187.96 - $245.29 $674,400 - $880,100
3,588 Added 35.97%
13,563 $2.67 Million
Q2 2024

Aug 13, 2024
BUY
$206.39 - $268.73 $120,325 - $156,669
583 Added 6.21%
9,975 $2.06 Million
Q1 2024

May 08, 2024
SELL
$203.52 - $273.43 $428,409 - $575,570
-2,105 Reduced 18.31%
9,392 $2.54 Million
Q4 2023

Feb 14, 2024
SELL
$164.52 - $238.84 $98,218 - $142,587
-597 Reduced 4.94%
11,497 $2.72 Million
Q3 2023

Nov 13, 2023
SELL
$194.44 - $217.61 $145,052 - $162,337
-746 Reduced 5.81%
12,094 $2.37 Million
Q2 2023

Aug 10, 2023
BUY
$183.71 - $210.25 $318,002 - $363,942
1,731 Added 15.58%
12,840 $2.7 Million
Q1 2023

May 11, 2023
BUY
$191.89 - $259.92 $665,858 - $901,922
3,470 Added 45.42%
11,109 $2.24 Million
Q4 2022

Feb 02, 2023
BUY
$197.11 - $250.07 $144,481 - $183,301
733 Added 10.61%
7,639 $1.66 Million
Q3 2022

Nov 04, 2022
SELL
$182.44 - $250.54 $147,958 - $203,187
-811 Reduced 10.51%
6,906 $1.36 Million
Q2 2022

Aug 01, 2022
SELL
$204.13 - $302.4 $601,775 - $891,475
-2,948 Reduced 27.64%
7,717 $1.65 Million
Q1 2022

May 10, 2022
SELL
$255.51 - $362.11 $77,419 - $109,719
-303 Reduced 2.76%
10,665 $3.03 Million
Q4 2021

Feb 08, 2022
BUY
$351.38 - $448.68 $871,773 - $1.11 Million
2,481 Added 29.23%
10,968 $4.13 Million
Q3 2021

Nov 12, 2021
SELL
$372.64 - $458.3 $64,094 - $78,827
-172 Reduced 1.99%
8,487 $3.5 Million
Q2 2021

Aug 13, 2021
BUY
$294.17 - $371.65 $1.15 Million - $1.45 Million
3,893 Added 81.68%
8,659 $3.2 Million
Q1 2021

May 14, 2021
SELL
$249.67 - $299.48 $7,240 - $8,684
-29 Reduced 0.6%
4,766 $1.38 Million
Q4 2020

Feb 09, 2021
BUY
$222.0 - $252.62 $128,760 - $146,519
580 Added 13.76%
4,795 $1.2 Million
Q3 2020

Nov 13, 2020
BUY
$175.56 - $226.45 $23,876 - $30,797
136 Added 3.33%
4,215 $954,000
Q2 2020

Aug 03, 2020
BUY
$118.84 - $189.72 $165,306 - $263,900
1,391 Added 51.75%
4,079 $711,000
Q1 2020

May 15, 2020
SELL
$98.9 - $178.34 $259,513 - $467,964
-2,624 Reduced 49.4%
2,688 $339,000
Q4 2019

Feb 12, 2020
BUY
$126.05 - $152.76 $61,386 - $74,394
487 Added 10.09%
5,312 $811,000
Q3 2019

Nov 12, 2019
SELL
$125.07 - $143.67 $30,016 - $34,480
-240 Reduced 4.74%
4,825 $639,000
Q2 2019

Aug 13, 2019
SELL
$123.4 - $148.55 $106,247 - $127,901
-861 Reduced 14.53%
5,065 $719,000
Q1 2019

May 15, 2019
BUY
$104.82 - $146.73 $138,467 - $193,830
1,321 Added 28.69%
5,926 $861,000
Q4 2018

Feb 14, 2019
SELL
$105.09 - $137.23 $111,080 - $145,052
-1,057 Reduced 18.67%
4,605 $521,000
Q3 2018

Nov 14, 2018
BUY
$112.11 - $134.54 $49,664 - $59,601
443 Added 8.49%
5,662 $762,000
Q2 2018

Aug 13, 2018
BUY
$102.37 - $117.25 $511 - $586
5 Added 0.1%
5,219 $586,000
Q1 2018

May 14, 2018
SELL
$98.19 - $115.2 $15,023 - $17,625
-153 Reduced 2.85%
5,214 $557,000
Q4 2017

Feb 14, 2018
BUY
$100.43 - $118.09 $120,616 - $141,826
1,201 Added 28.83%
5,367 $587,000
Q3 2017

Nov 13, 2017
SELL
$96.72 - $109.26 $11,703 - $13,220
-121 Reduced 2.82%
4,166 $450,000
Q2 2017

Aug 11, 2017
BUY
N/A
4,287
4,287 $434,000

Others Institutions Holding CRL

# of Institutions
710
Shares Held
53.9M
Call Options Held
122K
Put Options Held
239K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.51B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email